Honest Comparison · April 2026
REMEVi vs. Ro (Roman)
We compared pricing, bilingual support, women's health, and patient experience across both platforms. Here's the honest breakdown.
Side-by-side
REMEVi vs. Ro feature by feature
Based on publicly available data, pricing pages, and patient reviews — April 2026.
| Feature | REMEVi | Ro (Roman) |
|---|---|---|
| GLP-1 best price | ✅ From $199/mo (52-week) — all-in | ~$179/mo + add-ons |
| Spanish language support | ✅ Fully bilingual (built-in) | ❌ English only |
| Women's health | ✅ Full program from day one | ✅ Limited selection |
| Data security | ✅ 0 breaches ever | ✅ Clean record |
| Hidden fees | ✅ None — all-inclusive | ⚠️ Add-on charges common |
| Support response time | ✅ 2-hour SLA guaranteed | ❌ 24–48 hours typical |
| LegitScript certified | ✅ Certified | ✅ Certified |
| Bilingual care coordinator | ✅ Assigned to every patient | ❌ Not offered |
Pricing and features subject to change. Always verify current pricing on each provider's website.
Price transparency
No bait-and-switch pricing
Ro's introductory prices often lead to additional charges — labs, quarterly consultations, titration supplies. REMEVi shows you the full price before you pay a cent. What you see is what you pay. Always.
Support & care
The support difference
Ro (Roman) is a well-established telehealth platform with a strong reputation in men's health and a growing GLP-1 program. On paper, the offerings look similar. In practice, the patient experience diverges in ways that matter significantly for long-term adherence and outcomes.
Response time: REMEVi guarantees a 2-hour response from a bilingual care coordinator during business hours. Ro typically operates on 24–48 hour response windows through asynchronous messaging. For patients in their first weeks on a GLP-1 medication — when side effects like nausea and fatigue are most common — waiting 24 hours for guidance is a real barrier to staying on the program.
Language: Ro operates exclusively in English. REMEVi is built bilingual — every element of the patient experience is available in English and Spanish natively, not through auto-translation. For approximately 62 million Spanish-speaking Americans, REMEVi is the only GLP-1 telehealth platform that serves them in their primary language.
Pricing transparency: Ro's advertised starting prices are competitive, but patients frequently report additional charges for labs, quarterly consultations, and supply upgrades. REMEVi's pricing is all-inclusive from day one — clinical review, medication, shipping, and care coordinator access are all included in the monthly rate. No surprises.
Women's health: Both platforms offer GLP-1 programs for women. REMEVi additionally offers a comprehensive women's health program including hormone replacement therapy, hair regrowth, skin health, and mental health support — all with bilingual care coordination.
FAQ
Common questions
REMEVi's GLP-1 program starts at $199/month on a 52-week plan ($279/month for monthly plans) all-inclusive. Ro's pricing starts around $179/month but commonly includes add-on charges for labs, consultations, or supply upgrades. REMEVi's price is transparent and all-in from day one.
Ro operates in English only. REMEVi is built bilingual - every intake form, provider note, and care coordinator message is available in fluent Spanish. For Spanish-speaking patients, REMEVi is the only true choice.
Both offer some women's health services, but REMEVi provides a comprehensive program including HRT, hair regrowth, skin health, and mental health support - all with bilingual care coordinators.
REMEVi beats Ro on price transparency, bilingual support, and response time. Our 2-hour SLA guarantee means you will hear from a real human in your language within 2 hours - Ro typically takes 24-48 hours.
Yes - switching is simple. Complete REMEVi's 5-minute intake, a clinical reviews your case within 24 hours, and your first shipment arrives within 5-7 business days. You can time your transition so you do not run out of medication.
Both REMEVi and Ro offer compounded semaglutide and compounded tirzepatide prescribed by licensed US providers and dispensed by state-licensed compounding pharmacies. Compounded medications are non-FDA-approved preparations and are not generic versions of, nor the same as, Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. REMEVi differentiates from Ro on bilingual support, response SLA, and price transparency.
Switch to REMEVi today
Clinical review in 24 hours. No insurance needed. From $199/mo on 52-week plan, all-inclusive.
Start free consultation